4D Molecular Therapeutics, Inc. (FDMT) has 8 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 6 sales totalling $4.4M. Most recent filing: Sept. 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 16, 2026 filed Sept. 14, 2026 | Kirn David See Remarks | −$811,004 | 58,333 | −7% | Yes | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 19, 2026 | Kirn David See Remarks | −$300,537 | 169,076 | −8% | Yes | |
|
|
||||||
| Aug. 17, 2026 filed Aug. 13, 2026 | Bizily Scott Chief Legal Officer | — | 0 | 0% | Yes | |
|
|
||||||
| Aug. 5, 2026 filed Aug. 4, 2026 | Kirn David See Remarks | −$274,596 | 26,842 | −3% | Yes | |
|
|
||||||
| Aug. 4, 2026 filed Aug. 3, 2026 | Kirn David See Remarks | −$124,722 | 12,415 | −1% | Yes | |
|
|
||||||
Showing the 5 most recent of 8 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free